Replication Stress Response Modifies Sarcomeric Cardiomyopathy Remodeling

• Published in: Journal of the American Heart Association 2021-08, Vol.10 (15), p.e021768-e021768
• Main Authors: Pal, Soumojit, Nixon, Benjamin R., Glennon, Michael S., Shridhar, Puneeth, Satterfield, Sidney L., Su, Yan Ru, Becker, Jason R.
• Format: Article
• Language: English
• Subjects: ataxia telangiectasia and rad3 related; cardiac myosin‐binding protein 3; cardiac troponin T2; cardiomyocyte hypertrophy; DNA damage; endoreplication; Original Research
• ISSN: 2047-9980; 2047-9980
• DOI: 10.1161/JAHA.121.021768

Background Sarcomere gene mutations lead to cardiomyocyte hypertrophy and pathological myocardial remodeling. However, there is considerable phenotypic heterogeneity at both the cellular and the organ level, suggesting modifiers regulate the effects of these mutations. We hypothesized that sarcomere dysfunction leads to cardiomyocyte genotoxic stress, and this modifies pathological ventricular remodeling. Methods and Results Using a murine model deficient in the sarcomere protein, Mybpc3−/− (cardiac myosin‐binding protein 3), we discovered that there was a surge in cardiomyocyte nuclear DNA damage during the earliest stages of cardiomyopathy. This was accompanied by a selective increase in ataxia telangiectasia and rad3‐related phosphorylation and increased p53 protein accumulation. The cause of the DNA damage and DNA damage pathway activation was dysregulated cardiomyocyte DNA synthesis, leading to replication stress. We discovered that selective inhibition of ataxia telangiectasia and rad3 related or cardiomyocyte deletion of p53 reduced pathological left ventricular remodeling and cardiomyocyte hypertrophy in Mybpc3−/− animals. Mice and humans harboring other types of sarcomere gene mutations also had evidence of activation of the replication stress response, and this was associated with cardiomyocyte aneuploidy in all models studied. Conclusions Collectively, our results show that sarcomere mutations lead to activation of the cardiomyocyte replication stress response, which modifies pathological myocardial remodeling in sarcomeric cardiomyopathy.